See more : National Australia Bank Limited (NAB.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Ivy Cosmetics Corporation (4918.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ivy Cosmetics Corporation, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- FineTek Co., Ltd. (4549.TWO) Income Statement Analysis – Financial Results
- CO2 Solutions Inc. (COSLF) Income Statement Analysis – Financial Results
- Hero Innovation Group Inc. (EAP.CN) Income Statement Analysis – Financial Results
- Karat Packaging Inc. (KRT) Income Statement Analysis – Financial Results
- Duni AB (publ) (DUNI.ST) Income Statement Analysis – Financial Results
Ivy Cosmetics Corporation (4918.T)
About Ivy Cosmetics Corporation
Ivy Cosmetics Corporation manufactures and sells cosmetics and beauty supplement products. The company offers penetrating beauty liquid, lotion/emulsion/cream, and cleansing/face wash products. It also offers optional care, makeup, hair care, and body care products; health food/equipment, UV protection, and men's cosmetics. The company was formerly known as Shirogane Corporation and changed its name to Ivy Cosmetics Corporation in October 1977. Ivy Cosmetics Corporation was incorporated in 1975 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 2.71B | 2.94B | 3.53B | 3.43B | 3.83B |
Cost of Revenue | 801.30M | 830.94M | 1.11B | 1.28B | 1.10B |
Gross Profit | 1.91B | 2.11B | 2.42B | 2.14B | 2.73B |
Gross Profit Ratio | 70.47% | 71.76% | 68.55% | 62.51% | 71.33% |
Research & Development | 137.07M | 0.00 | 195.16M | 0.00 | 205.64M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.57B | 0.00 | 2.12B | 0.00 | 2.58B |
Other Expenses | 0.00 | 5.02M | 10.02M | -3.05M | 0.00 |
Operating Expenses | 1.73B | 2.13B | 2.34B | 2.12B | 2.79B |
Cost & Expenses | 2.53B | 2.96B | 3.45B | 3.40B | 3.89B |
Interest Income | 863.00K | 3.88M | 5.41M | 8.80M | 1.71M |
Interest Expense | 9.36M | 12.39M | 16.71M | 21.93M | 23.26M |
Depreciation & Amortization | 45.70M | 51.67M | 86.42M | 105.74M | 94.03M |
EBITDA | 242.60M | -33.16M | 185.13M | 255.05M | 152.80M |
EBITDA Ratio | 8.94% | 1.44% | 5.23% | 7.76% | 1.02% |
Operating Income | 187.07M | -18.07M | 83.28M | 24.82M | -54.91M |
Operating Income Ratio | 6.89% | -0.61% | 2.36% | 0.72% | -1.43% |
Total Other Income/Expenses | 473.00K | -79.16M | -1.57M | 100.25M | 79.85M |
Income Before Tax | 187.54M | -97.22M | 81.71M | 125.07M | 24.93M |
Income Before Tax Ratio | 6.91% | -3.30% | 2.31% | 3.65% | 0.65% |
Income Tax Expense | 27.23M | 287.39M | 41.34M | 148.30M | -20.97M |
Net Income | 160.31M | -384.61M | 40.38M | -23.23M | 45.91M |
Net Income Ratio | 5.91% | -13.07% | 1.14% | -0.68% | 1.20% |
EPS | 32.16 | -79.03 | 2.33 | -6.00 | 11.90 |
EPS Diluted | 32.16 | -79.03 | 2.32 | -6.00 | 11.90 |
Weighted Avg Shares Out | 4.98M | 4.87M | 4.46M | 3.87M | 3.86M |
Weighted Avg Shares Out (Dil) | 4.98M | 4.87M | 4.46M | 3.87M | 3.86M |
Source: https://incomestatements.info
Category: Stock Reports